BIOTRANSFORMATION OF CERTAIN GYRASE INHIBITORS

被引:17
作者
BORNER, K [1 ]
LODE, H [1 ]
机构
[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,MED KLIN & POLIKLIN,D-1000 BERLIN 45,FED REP GER
关键词
D O I
10.1007/BF01645200
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:S54 / S59
页数:6
相关论文
共 20 条
[1]   DETERMINATION OF NORFLOXACIN, A NEW NALIDIXIC-ACID ANALOG, IN HUMAN-SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BOPPANA, VK ;
SWANSON, BN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (05) :808-810
[2]  
BORNER K, 1984, FORTSCHR ANTIMIKROB, V3, P695
[3]  
BORNER K, 1984, UNPUB
[4]  
BORNER K, 1985, UNPUB
[5]  
BORNER K, 1984, 8TH INT S COL LIQ CH
[6]   FORMATION OF IDENTICAL METABOLITES FROM PIPERAZINE-SUBSTITUTED AND DIMETHYLAMINO-SUBSTITUTED PHENOTHIAZINE DRUGS IN MAN, RAT AND DOG [J].
BREYER, U ;
GAERTNER, HJ ;
PROX, A .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (02) :313-322
[7]  
DAGROSA E, 1984, FORTSCHR ANTIMIKR AN, V3, P665
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURE FOR THE QUANTITATION OF NORFLOXACIN IN URINE, SERUM AND TISSUES [J].
FORCHETTI, C ;
FLAMMINI, D ;
CARLUCCI, G ;
CAVICCHIO, G ;
VAGGI, L ;
BOLOGNA, M .
JOURNAL OF CHROMATOGRAPHY, 1984, 309 (01) :177-182
[9]  
GOODMAN, 1980, PHARM BASIS THERAPEU, P1023
[10]  
GRABER H, 1976, INT J CLIN PHARM BI, V13, P76